Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. It blocks viral entry into host cells while preserving normal immunologic function. The Company is also investigating an intramuscular method of administration of Trogarzo. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy.

TSX:TH - Post by User

Theratechnologies Inc > Addressable market

<< Previous

Bullboard Posts

Next >>

Comment by scarlet1967on May 05, 2023 12:01pm

83 Views

Post# 35433148

RE:RE:RE:RE:RE:RE:RE:RE:Addressable market

External Comparison of Ibalizumab in Trials vs. Other Regimens in OPERA - Full Text View - ClinicalTrials.gov

The trial was conducted by a third party!

"Sponsor:

Epividian

Collaborators:

Theratechnologies

FIECON

Information provided by (Responsible Party):

Epividian"

SPCEO1 wrote: There are FDA restrictions on what they can use in their sales ptiches - I am not sure yet if they will be able to use this directly or only indirectly when they are speaking with doctors. I suspect they will be able to use it directly but since THTX sponsored the work, maybe that makes it less usable as it is viewed as biased? Maybe they can only refer to it va their MSL's in teaching sessions they hold for doctors and their staff? I am just not sure how they can use it at this point. Also, their sales team is unlikely to get many one on one meetings with doctors for Trogarzo at this point, but if they can use this as a way to get such meetings, it could prove to be very helpful. Either way, it is not something where we should expect to see an immediate jump higher in sales, it will take time to get the message out.
palinc2000 wrote: You have doubts about THTX being able to cummunicate effectively to doctors!!!!!!!
Are you serious?

SPCEO1 wrote: Yes, I believe that is correct. And it could prove very helpful to sales but it is still hard to beat a pill even then. That data reported yesterday, however, if THTX is able to communicate it effectively to doctors, may be enough for patients to be willing to take the Trogarzo shot over competing pills. But don't expect immediate results on the Trogarzo sales front as it will take time for that data to be spread to doctors and my guess is patients are still likely to opt for pills unless their doctor makes a really convincing case to them. Some doctors will and some won't. So, it should help Trogarzo sales but time will tell by how much.

LouisW wrote: Your "simple at home" comment really interests me. Are you saying IM can be performed at home by themself? Patients no need to go to hospital?